← FDA Warning Letters
Hybrid Pharma, LLC
FDA Warning Letter · 2022-06-14 · Office of Pharmaceutical Quality Operations, Division II
Letter
- Company
- Hybrid Pharma, LLC
- Posted Date
- 2022-06-14
- Letter Issue Date
- 2022-06-07
- Issuing Office
- Office of Pharmaceutical Quality Operations, Division II
Subject
Compounding Pharmacy/Adulterated Drug Products
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown